today announced an update of plans for the commercial launch of Symvess (acellular tissue engineered vessel-tyod) for extremity arterial injury. Humacyte is responding to requests for quotations ...

Symvess, or the ATEV™ (acellular tissue engineered vessel ... of Infectious Diseases SYMVESS is manufactured using cells and reagents that may transmit infectious diseases or infectious ...